{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:07:59Z","timestamp":1789769279261,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In a multicentre randomised controlled trial (DIRECT), we evaluate whether an intervention of providing direct letters from healthcare professionals to at-risk relatives (ARRs) affects the proportion of ARRs contacting a cancer genetics clinic, compared with patient-mediated disclosure alone (control). With the aim to explore how the patients included in the trial perceived and performed risk communication with their ARRs we analysed 17 semi-structured interviews with reflexive thematic analysis. All patients described that they disclosed risk information to all close relatives themselves. No integrity-related issues were reported by patients offered the intervention, and all of them accepted direct letters to all their ARRs. Patients\u2019 approaches to informing distant relatives were unpredictable and varied from contacting all distant ARRs, sharing the burden with the family, utilising the offer of sending direct letters, vaguely relying on others to inform, or postponing disclosure. Most patients limited their responsibility to the disclosure, although others wanted relatives to get genetic counselling or felt a need to provide additional information to the ARRs before ending their mission. We also identified confusion about the implication of test results, who needed risk information, and who was responsible for informing ARRs. These misunderstandings possibly also affected risk disclosure. This study revealed that despite accepting the direct letters to be sent to all relatives, the patients also contributed to risk disclosure in other ways. It was only in some situations to distant relatives that the healthcare-assisted letter was the only means of communication to the ARRs.<\/jats:p>","DOI":"10.1038\/s41431-024-01544-8","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T01:02:25Z","timestamp":1706835745000},"page":"448-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patients\u2019 perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure"],"prefix":"10.1038","volume":"32","author":[{"given":"Charlotta","family":"N\u00e4\u00e4s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2978-1416","authenticated-orcid":false,"given":"Jenny","family":"von Salom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-2395","authenticated-orcid":false,"given":"Anna","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"1544_CR1","first-page":"49","volume":"10","author":"AE Prince","year":"2017","unstructured":"Prince AE, Cadigan RJ, Henderson GE, Evans JP, Adams M, Coker-Schwimmer E. et al. Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review. Pharmacogenomics Pers Med.2017;10:49\u201360.","journal-title":"Pharmacogenomics Pers Med."},{"key":"1544_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2019.8430","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson HD, Pappas M, Cantor A, Haney E, Holmes R. Risk Assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. Jama. 2019;322:666\u201385.","journal-title":"Jama"},{"key":"1544_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020;69:411\u201344.","journal-title":"Gut"},{"key":"1544_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41431-022-01200-z","volume":"31","author":"AL Young","year":"2023","unstructured":"Young AL, Imran A, Spoelma MJ, Williams R, Tucker KM, Halliday J, et al. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review. Eur J Hum Genet. 2023;31:18\u201334.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR5","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.pecinn.2023.100138","volume":"2","author":"MD Ahsan","year":"2023","unstructured":"Ahsan MD, Levi SR, Webster EM, Bergeron H, Lin J, Narayan P, et al. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis. PEC Innov. 2023;2:100138.","journal-title":"PEC Innov"},{"key":"1544_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10897-005-0412-3","volume":"14","author":"CL Gaff","year":"2005","unstructured":"Gaff CL, Collins V, Symes T, Halliday J. Facilitating family communication about predictive genetic testing: probands\u2019 perceptions. J Genet Couns. 2005;14:133\u201340.","journal-title":"J Genet Couns"},{"key":"1544_CR7","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1200\/JCO.22.00303","volume":"40","author":"MK Frey","year":"2022","unstructured":"Frey MK, Ahsan MD, Bergeron H, Lin J, Li X, Fowlkes RK, et al. Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis. J Clin Oncol. 2022;40:4129\u201343.","journal-title":"J Clin Oncol"},{"key":"1544_CR8","doi-asserted-by":"crossref","unstructured":"Menko FH, van der Velden SL, Griffioen DN, Ait Moha D, Jeanson KN, Hogervorst FBL, et al. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1\/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. 2023 [Internet]. Aug 21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37605508.","DOI":"10.1002\/jgc4.1767"},{"key":"1544_CR9","unstructured":"National clinical guidelines of breast cancer management [Internet]. Confederation of Regional Cancer Centres in Sweden. [cited 2023 Sept 10]. Available from: https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/brostcancer\/vardprogram\/."},{"key":"1544_CR10","unstructured":"National clinical guidelines of colorectal cancer management [Internet]. Confederation of Regional Cancer Centres in Sweden. [cited 2023 Sept 10]. Available from: https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/tjock-och-andtarmscancer\/vardprogram\/."},{"key":"1544_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07829-5","volume":"24","author":"C Hawranek","year":"2023","unstructured":"Hawranek C, Ehrencrona H, Ofverholm A, Hellquist BN, Rosen A. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study). Trials. 2023;24:810.","journal-title":"Trials"},{"key":"1544_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","volume":"11","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport, Exerc Health. 2019;11:589\u201397.","journal-title":"Qual Res Sport, Exerc Health"},{"key":"1544_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"1544_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1034\/j.1399-0004.2003.00142.x","volume":"64","author":"K Forrest","year":"2003","unstructured":"Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet. 2003;64:317\u201326.","journal-title":"Clin Genet"},{"key":"1544_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/sj.ejhg.5201883","volume":"15","author":"CL Gaff","year":"2007","unstructured":"Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, et al. Process and outcome in communication of genetic information within families: a systematic review. Eur J Hum Genet. 2007;15:999\u20131011.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13053-019-0114-8","volume":"17","author":"KM McGarragle","year":"2019","unstructured":"McGarragle KM, Hare C, Holter S, Facey DA, McShane K, Gallinger S, et al. Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study. Hered Cancer Clin Pr. 2019;17:16.","journal-title":"Hered Cancer Clin Pr"},{"key":"1544_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/jpm11060538","volume":"11","author":"NB Henrikson","year":"2021","unstructured":"Henrikson NB, Blasi P, Figueroa Gray M, Tiffany BT, Scrol A, Ralston JD, et al. Patient and family preferences on health system-led direct contact for cascade screening. J Pers Med. 2021;11:538.","journal-title":"J Pers Med"},{"key":"1544_CR18","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/jpm12081249","volume":"12","author":"C Pedrazzani","year":"2022","unstructured":"Pedrazzani C, Aceti M, Schweighoffer R, Kaiser-Grolimund A, B\u00fcrki N, Chappuis PO, et al. The communication chain of genetic risk: analyses of narrative data exploring proband\u2013provider and proband\u2013family communication in hereditary breast and ovarian cancer. J Pers Med. 2022;12:1249.","journal-title":"J Pers Med"},{"key":"1544_CR19","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41431-020-00725-5","volume":"28","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28:1631\u201344.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40142-016-0088-z","volume":"4","author":"MB Daly","year":"2016","unstructured":"Daly MB. Family communication of genetic risk: a personalized approach. Curr Genet Med Rep. 2016;4:35\u201340.","journal-title":"Curr Genet Med Rep."},{"key":"1544_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41431-021-00890-1","volume":"30","author":"KS Finn","year":"2022","unstructured":"Finn KS, Pacyna J, Azevedo Tsou C, Jewel Samadder N, Sharp R. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. Eur J Hum Genet. 2022;30:53\u201361.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR22","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1158\/1940-6207.CAPR-20-0141","volume":"13","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan S, Hampel H, Leeman J, Patel A, Kulchak Rahm A, Reuland DS, et al. Stakeholder perspectives on overcoming barriers to cascade testing in Lynch syndrome: a qualitative study. Cancer Prev Res. 2020;13:1037\u201346.","journal-title":"Cancer Prev Res"},{"key":"1544_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41431-023-01400-1","volume":"31","author":"LM Ballard","year":"2023","unstructured":"Ballard LM, Band R, Lucassen AM. Interventions to support patients with sharing genetic test results with at-risk relatives: a synthesis without meta-analysis (SWiM). Eur J Hum Genet. 2023;31:988\u20131002.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ejhg.2015.174","volume":"24","author":"A Mendes","year":"2016","unstructured":"Mendes A, Paneque M, Sousa L, Clarke A, Sequeiros J. How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence. Eur J Hum Genet. 2016;24:315\u201325.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10689-010-9385-y","volume":"10","author":"J Vos","year":"2011","unstructured":"Vos J, Menko F, Jansen AM, van Asperen CJ, Stiggelbout AM, Tibben A. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1\/2-test results between proband and relatives. Fam Cancer. 2011;10:87\u201396.","journal-title":"Fam Cancer"},{"key":"1544_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ejhg.2014.84","volume":"23","author":"C Jacobs","year":"2015","unstructured":"Jacobs C, Dancyger C, Smith JA, Michie S. Accuracy of recall of information about a cancer-predisposing BRCA1\/2 gene mutation among patients and relatives. Eur J Hum Genet. 2015;23:147\u201351.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41431-021-00993-9","volume":"30","author":"LM van den Heuvel","year":"2022","unstructured":"van den Heuvel LM, Hoedemaekers YM, Baas AF, Baars MJH, van Tintelen JP, Smets EMA, et al. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet. 2022;30:203\u201310.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41431-018-0310-4","volume":"27","author":"C Jacobs","year":"2019","unstructured":"Jacobs C, Patch C, Michie S. Communication about genetic testing with breast and ovarian cancer patients: a scoping review. Eur J Hum Genet. 2019;27:511\u201324.","journal-title":"Eur J Hum Genet"},{"key":"1544_CR29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jgc4.1143","volume":"28","author":"LM van den Heuvel","year":"2019","unstructured":"van den Heuvel LM, Smets EMA, van Tintelen JP, Christiaans I. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes. J Genet Couns. 2019;28:1042\u201358.","journal-title":"J Genet Couns"},{"key":"1544_CR30","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.pec.2018.05.009","volume":"101","author":"W Eijzenga","year":"2018","unstructured":"Eijzenga W, de Geus E, Aalfs CM, Menko FH, Sijmons RH, de Haes H, et al. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial. Patient Educ Couns. 2018;101:1611\u20139.","journal-title":"Patient Educ Couns"},{"key":"1544_CR31","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.3390\/cancers13246254","volume":"13","author":"C Pedrazzani","year":"2021","unstructured":"Pedrazzani C, Ming C, Burki N, Caiata-Zufferey M, Chappuis PO, Duquette D, et al. Genetic literacy and communication of genetic information in families concerned with hereditary breast and ovarian cancer: a cross-study comparison in two countries and within a timeframe of more than 10 years. Cancers. 2021;13:6254.","journal-title":"Cancers"},{"key":"1544_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pec.2014.09.017","volume":"98","author":"J Paul","year":"2015","unstructured":"Paul J, Metcalfe S, Stirling L, Wilson B, Hodgson J. Analyzing communication in genetic consultations-a systematic review. Patient Educ Couns. 2015;98:15\u201333.","journal-title":"Patient Educ Couns"},{"key":"1544_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12687-019-00412-z","volume":"10","author":"NB Henrikson","year":"2019","unstructured":"Henrikson NB, Blasi PR, Fullerton SM, Grafton J, Leppig KA, Jarvik GP, et al. \u201cIt would be so much easier\u201d: health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system. J Community Genet. 2019;10:461\u201370.","journal-title":"J Community Genet"},{"key":"1544_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/medethics-2015-102781","volume":"42","author":"S Dheensa","year":"2016","unstructured":"Dheensa S, Fenwick A, Lucassen A. \u2018Is this knowledge mine and nobody else\u2019s? I don\u2019t feel that.\u2019 Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Eth. 2016;42:174\u20139.","journal-title":"J Med Eth"},{"key":"1544_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2471\/BLT.14.141390","volume":"93","author":"NT Tam","year":"2015","unstructured":"Tam NT, Huy NT, Thoa le TB, Long NP, Trang NT, Hirayama K, et al. Participants\u2019 understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis. Bull World Health Organ. 2015;93:186\u201398H.","journal-title":"Bull World Health Organ"},{"key":"1544_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-022-01142-9","volume":"8","author":"PR Blasi","year":"2022","unstructured":"Blasi PR, Scrol A, Anderson ML, Gray MF, Tiffany B, Fullerton SM, et al. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation. Pilot Feasibility Stud. 2022;8:174.","journal-title":"Pilot Feasibility Stud"},{"key":"1544_CR37","doi-asserted-by":"publisher","first-page":"e26264","DOI":"10.2196\/26264","volume":"10","author":"S Kim","year":"2021","unstructured":"Kim S, Aceti M, Baroutsou V, Burki N, Caiata-Zufferey M, Cattaneo M, et al. Using a Tailored Digital Health Intervention for family communication and cascade genetic testing in Swiss and Korean families with hereditary breast and ovarian cancer: protocol for the DIALOGUE study. JMIR Res Protoc. 2021;10:e26264.","journal-title":"JMIR Res Protoc"},{"key":"1544_CR38","doi-asserted-by":"publisher","first-page":"e46571","DOI":"10.2196\/46571","volume":"25","author":"E Siglen","year":"2023","unstructured":"Siglen E, Vetti HH, Augestad M, Steen VM, Lunde A, Bjorvatn C. Evaluation of the Rosa chatbot providing genetic information to patients at risk of hereditary breast and ovarian cancer: qualitative interview study. J Med Internet Res. 2023;25:e46571.","journal-title":"J Med Internet Res"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01544-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T19:06:27Z","timestamp":1712516787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01544-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3059292\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Swedish Ethical Review Authority (2019-02647). Informed written consent was obtained from all participants. As the interviews might induce unpleasant feelings in the patient, we were attentive to these during the interviews and were prepared to offer counselling if needed. If misunderstandings were apparent, we tried to clarify clinically relevant information after the interviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}